The market model places Biosense Webster, Abbott and Medtronic as market leaders. "Kardium’s pulsed field ablation clinical trial enters final stages" was originally created and published by ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

C. In February of 2024, Bon Secours St. Mary’s Hospital in Richmond became the first hospital in the Commonwealth of Virginia ...

Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool ...

Bernstein analyst Lee Hambright lowered the firm’s price target on Abbott (ABT ... that include robotic-assisted surgery, pulsed field ablation, insulin pumps, and new AI-enabled functionality ...

The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the ...

After more than a monthlong pause in response to four neurovascular events linked to its Varipulse pulsed-field ablation system, Johnson & Johnson announced late last week that it will resume use of ...

Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...